+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine

Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine

Vaccine 35(6): 882-888

Chickens are commonly processed around 35-45days of age in broiler chicken industry hence; diseases that occur at a young age are of paramount economic importance. Early age infection with infectious bursal disease virus (IBDV) results in long-lasting immunosuppression and profound economic losses. To our knowledge, this is the first study comparing the protection efficacy of modified live (MdLV) IBDV and herpesvirus turkey (HVT)-IBDV vaccines against early age variant IBDV (varIBDV) infection in chicks. Experiments were carried out in IBDV maternal antibody (MtAb) positive chicks (n=330), divided into 6 groups (n=50-60/group), namely Group 1 (saline), Group 2 (saline+varIBDV), Group 3 (HVT-IBDV), Group 4 (HVT-IBDV+varIBDV), Group 5 (MdLV) and Group 6 (MdLV+varIBDV). HVT-IBDV vaccination was given via the in ovo route to 18-day-old embryonated eggs. MdLV was administered via the subcutaneous route in day-old broilers. Group 2, Group 4 and Group 6 were orally challenged with varIBDV (SK-09, 3×103 EID50) at day 6 post-hatch. IBDV seroconversion, bursal weight to body weight ratio (BBW) and bursal histopathology were assessed at 19 and 35days of age. Histopathological examination at day 19 revealed that varIBDV-SK09 challenge caused severe bursal atrophy and lower BBW in HVT-IBDV but not in MdLV vaccinated chicks. However by day 35, all challenged groups showed bursal atrophy and seroconversion. Interestingly, RT-qPCR analysis after varIBDV-SK09 challenge demonstrated an early (9days of age) and significantly high viral load (∼5744 folds) in HVT-IBDV vaccinated group vs unvaccinated challenged group (∼2.25 folds). Furthermore, flow cytometry analysis revealed inhibition of cytotoxic CD8+ T-cell response (CD44-downregulation) and decreased splenic lymphocytes counts in chicks after HVT-IBDV vaccination. Overall, our data suggest that MdLV delays varIBDV pathogenesis, whereas, HVT-IBDV vaccine is potentially immunosuppressive, which may increase the risk of early age varIBDV infection in broilers.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 059980843

Download citation: RISBibTeXText

PMID: 28089549

DOI: 10.1016/j.vaccine.2017.01.005

Related references

Performance of broiler chickens given either a complex of infectious bursal disease vaccine conjugated with IBDV neutralizing antibody or a commercial IBDV vaccine. Poultry Science 74(Suppl. 1): 24, 1995

Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain. Avian Diseases 53(4): 624-628, 2009

Efficacy of Single Dose Recombinant Herpesvirus of Turkey Infectious Bursal Disease Virus (Ibdv) Vaccination against a Variant Ibdv Strain. Avian Diseases 53(4): 624-628, 2009

Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211(2): 481-490, 1995

Detection of protective titres against virulent infectious bursal disease virus (IBDV) in chicks vaccinated with bivalent live IBDV vaccine. Acta Agriculturae Boreali Sinica 14(2): 133-138, 1999

Determination of optimum formulation of a novel infectious bursal disease virus (IBDV) vaccine constructed by mixing bursal disease antibody with IBDV. Avian Diseases 39(4): 687-699, 1995

Recombinant MDV expressing vp2 gene of infectious bursal disease virus (IBDV) induced protection against virulent IBDV in chickens with or without maternal antibodies. Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine 29(10): 791-795, 2007

Local field isolates of infectious bursal disease virus (IBDV) in Bangladesh can induce higher immune response in chickens than that of the commercially available IBDV vaccines. Journal of Animal and Veterinary Advances 3(2): 112-114, 2004

Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV. Vaccine 30(12): 2125-2130, 2012

A field study on the significance of vaccination against infectious bursal disease virus (IBDV) at the optimal time point in broiler flocks with maternally derived IBDV antibodies. Avian Pathology 36(5): 401-409, 2007

Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 257(2): 352-362, 1999

Pathological changes in specific pathogen free chickens experimentally inoculated with highly virulent field isolate of infectious bursal disease virus (IBDV) in comparison with vaccinal strain of IBDV. Zbornik Veterinarske Fakultete Univerza Ljubljana 34(2): 177-186, 1997

Studies on interferon induction by infectious bursal disease virus (IBDV). II. Interferon production in White Leghorn chickens infected with an attenuated or pathogenic isolant of IBDV. Avian Diseases 23(3): 634-645, 1979

Molecular characterization of infectious bursal disease virus (IBDV): diversity of very virulent IBDV in Tanzania. Archives of Virology 152(4): 783-790, 2007

Processing of infectious bursal disease virus (IBDV) polyprotein and self-assembly of IBDV-like particles in Hi-5 cells. Biotechnology Progress 22(3): 763-769, 2006